Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
European Journal of Immunology|July 20, 2004
Peritoneal and splenic B-1 cells are separable by phenotypic, functional, and transcriptomic characteristicsJoseph R Tumang, William D Hastings, Chunyan Bai, et al.European Journal of Immunology|April 13, 2006
Peritoneal B-2 cells comprise a distinct B-2 cell population with B-1b-like characteristicsWilliam D Hastings, Joseph R Tumang, Timothy W Behrens, et al.Immunology Letters|February 17, 2006
CD5+/Mac-1- peritoneal B cells: a novel B cell subset that exhibits characteristics of B-1 cellsWilliam D Hastings, Sean M Gurdak, Joseph R Tumang, et al.Nature|May 13, 2008
IL-21 and TGF-beta are required for differentiation of human T(H)17 cellsLi Yang, David E Anderson, Clare Baecher-Allan, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2002
BCR engagement induces Fas resistance in primary B cells in the absence of functional Bruton's tyrosine kinaseJoseph R Tumang, Robert S Negm, Laura A Solt, et al.Autoimmunity|March 15, 2005
Interleukin-4 produces a breakdown of tolerance in vivo with autoantibody formation and tissue damageLinda C Foote, John W Evans, Justin M Cifuni, et al.European Journal of Immunology|August 14, 2009
TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokinesWilliam D Hastings, David E Anderson, Nasim Kassam, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 26, 2010
TGF-beta induces IL-9 production from human Th17 cellsGaëlle Beriou, Elizabeth M Bradshaw, Ester Lozano, et al.Science (New York, N.Y.)|November 17, 2007
Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cellsAna C Anderson, David E Anderson, Lisa Bregoli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2020
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase SignalingChen Liu, Hengyu Lu, Hongyun Wang, et al.Pageof 2